Highvista Strategies LLC / FULC
Highvista Strategies LLC’s Fulcrum Therapeutics Inc Position
Does Highvista Strategies LLC own Fulcrum Therapeutics Inc (FULC)? Not currently — the last reported position was 90.0K shares worth $2M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q4 2021
Shares
90.0K
% of Portfolio
+1.27%
Quarters Held
1
position exited
Position History FULC
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2021 | 90.0K | $2M | +1.27% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of FULC.